Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05891418 · ClinicalTrials.gov registry record · NA
Effect of Email Nudges on Plan Switching and Healthcare Utilization Among Unemployment Insurance Recipients
A NA study, sponsored by Office of Evaluation Sciences.
- Completed
- Registry status
- NA
- Development phase
- 42,470
- Enrollment target
NCT05891418: Completed NA study, sponsored by Office of Evaluation Sciences.
NCT05891418 is a NA study that has completed, run by Office of Evaluation Sciences. The registered enrollment target is 42,470 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2927% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05891418, a NA study, has completed, sponsored by Office of Evaluation Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 42,470 participants
- Enrollment target
Study Summary
In March 2021, President Biden signed into law the American Rescue Plan Act of 2021 (ARP), a landmark federal economic relief and stimulus package designed to provide support to Americans hit by the economic recession brought about by the COVID-19 global pandemic. The law provides increased federal premium tax credits (PTC), and ensures that consumers will pay no more than 8.5 percent of household income on health insurance premiums in 2021 and 2022, if enrolled through an Affordable Care Act marketplace like Covered California. The ARP also provides additional PTC and cost-sharing reduction (CSR) benefits to eligible marketplace enrollees who report receiving unemployment insurance benefits (UIB) for at least one week in 2021. Under the law, for 2021 only, Covered California consumers will have their household income level treated as if it were at 138.1 percent of the federal poverty level (FPL), regardless of their projected annual income, which will make them eligible for a Silver 94 plan, and which offers the greatest value on cost-sharing benefits. But in order to access those cost-sharing benefits, households must be in silver tier plans, but over 40,000 were not. This project's goal is to assess the effects of an informational email on plan switching into Cost Sharing Reduction Silver plans and downstream healthcare utilization. The project's research design is a randomized intervention among approximately 42,500 enrolled households with an email address in non-silver tier plans. The investigators randomly assigned to either two informational emails or to a no email control group. The investigators then collected administrative data to examine plan switching behavior and healthcare utilization among households in the study.
Primary Outcome
Percent of households enrolled in a Cost-Sharing Reduction Silver Plan
Interventions
- BEHAVIORAL Two informational emails with plan information
- BEHAVIORAL Standard notice of eligibility determination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42,470 participants |
| Start Date | 2021-06-25 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
What the finished NCT05891418 record still lists
NCT05891418 is an interventional study that assigns participants to a tested intervention. Its 42,470 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2927% higher).
The record links to 0 conditions, and to 2 interventions - of which Two informational emails with plan information is the first listed.
NCT05891418 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05891418 about?
NCT05891418 is a clinical study titled "Effect of Email Nudges on Plan Switching and Healthcare Utilization Among Unemployment Insurance Recipients". In March 2021, President Biden signed into law the American Rescue Plan Act of 2021 (ARP), a landmark federal economic relief and stimulus package designed to provide support to Americans hit by the economic recession brought about by the COVID-19 global pandemic. The law provides increased federal ...
What is the current status of trial NCT05891418?
This trial is currently completed. It is a NA study. The enrollment target is 42,470 participants. The study started on 2021-06-25. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT05891418?
The interventions under investigation include: Two informational emails with plan information (BEHAVIORAL), Standard notice of eligibility determination (BEHAVIORAL).
Who is sponsoring clinical trial NCT05891418?
This trial is sponsored by Office of Evaluation Sciences, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05891418's enrollment target sits among peer trials
42,470 7th of 2000 higher than 1,994 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01255748 · 40,000 participants
Registry Study for Radiation Therapy Outcomes
- NCT04994756 · 40,000 participants
Stroke Thrombectomy and Aneurysm Registry
- NCT06768814 · 40,000 participants · NA
Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data
- NCT07109427 · 40,000 participants · NA
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI